Vanda Pharma (NASDAQ:VNDA) reported quarterly earnings results on February 11, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-2.39, missing the consensus estimate of $-1.67 by $0.72 per share. Revenue came in at $57.2M, missing the estimate of $59.1M.
Vanda Pharma's stock moved following the earnings release. The stock currently trades at $6.12 with a market capitalization of $390.0M.